Vitruvias intros generic K-TabK-Tab and potassium chloride extended-release tablets had a market value of approximately $346 million for the 12 months ended March 2020, according to IQVIA. Aurobindo gets FDA green light for generic ProAmatineAurobindo's generic ProAmatine tablets provide a treatment for orthostatic hypotension. Dr. Reddy's unveils generic Ciprodex Ciprodex had a market value of approximately $453 million for the most recent 12 months ended June 2020, according to IQVIA. Alembic receives FDA blessing for Levitra generic Vardenafil hydrochloride tablets have a market value of roughly $35 million for the 12 months ended June 2020, according to IQVIA. Camber launches generic Yaz Camber is releasing generic Yaz in 3 mg/0.02 mg in three blister cards of 28 tablets. Lupin launches generic Zyflo CR Zileuton extended-release tablets had an annual market value of approximately $40 million, according to IQVIA June 2020 data. AAM taps new state government affairs vice president The Association for Accessible Medicines appointed Lisa Steelman to the role of vice president of state government affairs, which monitors legislation and regulation within the generic industry. Camber intros mesalamine suppositories Camber's generic Canasa suppositories treat mild to moderate ulcerative colitis. Aurobindo obtains FDA nod for 2 generics Aurobindo's newly approved Gleevac and Armidex generics provide treatment options for various types of cancer. FDA gives Lupin tentative nod for generic Jardiance Empagliflozin tablets, 10 mg and 25 mg had a market value of roughly $4.4 billion, according to IQVIA March 2020 data. First Previous 134 135 136 137 138 Next Last